Skip to content
  • Sunday, 26 July 2026
  • 4:38 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Rethinking Evidence Generation for Ultra-Rare Diseases
Laboratory Automation & Robotics

Rethinking Evidence Generation for Ultra-Rare Diseases

Lana Keisha May 2, 2026 0

The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the U.S. Food and Drug…

Read More
Neuroscience & Brain Research

Rethinking Artificial Intelligence in Cognitive Science as New Research Challenges the Centaur Model

Rifan Muazin Apr 30, 2026 0

The intersection of cognitive psychology and artificial intelligence has long been a frontier of scientific inquiry, driven by the ambition…

Read More
Neuroscience & Brain Research

Rethinking Metabolic Control: How Astrocytes and Tanycytes Drive Brain Signaling for Hunger and Satiety

Rifan Muazin Apr 29, 2026 0

For decades, the scientific understanding of how the human brain regulates appetite has been almost exclusively focused on the activity…

Read More
Laboratory Automation & Robotics

Rethinking Evidence Generation for Ultra-Rare Diseases

Lana Keisha Apr 25, 2026 0

Developing effective treatments for ultra-rare diseases has long presented a profound paradox for the biopharmaceutical industry and regulatory bodies. While…

Read More
Advanced Materials Science

Rethinking Tribology: Researchers Discover Contactless Magnetic Friction and the Breakdown of Amontons Law

Nila Kartika Wati Apr 6, 2026 0

In a discovery that challenges three centuries of physical principles, researchers at the University of Konstanz have identified a novel…

Read More

Posts pagination

1 2
Naturally occurring mechanism hampers fertilitySolving the Two-Century Geological Mystery of the Dolomite Problem through Atomic Simulation and Pulsed GrowthAI Lab Result Interpretation Gains Traction with Patients, but Raises Accuracy and Validation Concerns for Clinical LaboratoriesScientists Recreate Human Bone Marrow in Laboratory Breakthrough for Cancer Research and Drug Development
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ